MEQUON, Wis. — Titan Spine, a medical device surface technology company focused on developing innovative spinal interbody fusion implants, announced today that it has named two spine surgeons to its Key Opinion Leader Advisory Team, Dr. Kade T. Huntsman of Salt Lake City, Utah and Dr. Axel Reinhardt of Potsdam, Germany. The new members bring broad experience in degenerative spine conditions and innovative interbody fusion techniques, and in their new roles will help guide the development of the Company’s Endoskeleton® Interbody Device portfolio.Paul Slosar, MD, Medical Director for Titan Spine, said, “We welcome Dr. Huntsman and Dr. Reinhardt to our Key Opinion Leader Advisory Team, where their thought leadership will be invaluable as we look to enhance our surface technology platform. Their clinical expertise and insights into fusion techniques will assist our efforts to build out our Endoskeleton implant portfolio for new applications in spine care, and help further our commitment to optimizing the outcomes of interbody fusion through the application of our surface technology expertise.”Dr. Huntsman is a board certified spine surgeon who specializes in degenerative spine conditions and spine trauma at St. Mark’s Hospital, LDS Hospital, and Salt Lake Orthopaedic Clinic in Salt Lake City, Utah. He has led research into the safety and efficacy of a variety of interbody fusion techniques, with a focus on the lateral approach. He is a member of numerous medical societies, including the American Academy of Orthopaedic Surgeons, the North American Spine Society, and the Scoliosis Research Society.Dr. Reinhardt is Head of the Department of Spinal Surgery at the Specialized Orthopaedic Hospital in Potsdam, Germany, and Medical Director of Oberlin Clinic, also in Potsdam. He is a founding member of the Spine Study Group, a multicenter initiative focused on investigating degenerative spine diseases and operative treatment results. Dr. Reinhardt is also a member of AO Spine and was the first in Europe to perform surgical cases using Titan Spine’s interbody fusion devices.
“Titan Spine’s surface technology has the potential to transform interbody fusion by enabling the device to actively contribute to bone formation at the implant site. I am excited to collaborate with the Company and fellow members of the Key Opinion Leader Team to further the development of this unique technology and its integration into spinal care,” said Dr. Huntsman.
Dr. Reinhardt commented, “The Endoskeleton devices provide an ideal environment for bone growth by promoting the body’s natural osteogenic response. They also offer advantages for efficient implantation and positioning in the disc space, with strong bone purchase, and in my experience, patients have achieved rapid and robust fusion. I look forward to helping guide the development of the technology and increasing awareness of its value among surgeons internationally.”
Titan Spine markets a full line of Endoskeleton interbody devices for use in the lumbar and cervical spine. The cages feature a proprietary acid-etched surface that is textured at the macro, micro and cellular levels to support bone purchase and new bone growth. Cellular research has demonstrated the surface promotes a superior bone-forming response as compared to smooth titanium and PEEK implants.
About Titan Spine
Titan Spine, LLC is a surface technology company focused on the design and manufacture of interbody fusion devices for the spine. The company is committed to advancing the science of surface engineering to enhance the treatment of various pathologies of the spine that require fusion. Titan Spine, located in Mequon, Wisconsin and Laichingen, Germany, markets a full line of Endoskeleton® interbody devices featuring its proprietary textured surface.
Titan Spine Announces New Appointments
(Visited 3 times, 2 visits today)